Regatul Unit - engleză - MHRA (Medicines & Healthcare Products Regulatory Agency)

rivopharm (uk) ltd - acarbose - oral tablet - 50mg

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose is contraindicated in patients with known hypersensitivity to the drug. acarbose is contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose is also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose is contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose is contraindicated in patients with known hypersensitivity to the drug. acarbose is contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose is also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose is contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose tablets, usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Canada - engleză - Health Canada

strides pharma canada inc - acarbose - tablet - 50mg - acarbose 50mg - alpha-glucosidase inhibitors

Canada - engleză - Health Canada

strides pharma canada inc - acarbose - tablet - 100mg - acarbose 100mg - alpha-glucosidase inhibitors

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

a-s medication solutions - acarbose (unii: t58msi464g) (acarbose - unii:t58msi464g) - acarbose tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. acarbose tablets are contraindicated in patients with known hypersensitivity to the drug. acarbose tablets are contraindicated in patients with diabetic ketoacidosis or cirrhosis. acarbose tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction. in addition, acarbose tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.